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Abstract
A method for determining mRNA half-lives in the polymorphic fungus Candida albicans is described. It employs growth in a defined medium, the inhibition of transcription with thiolutin (10–20 μg/mL), and quantitative Northern blotting. The
method is effective for the A72, SC5314, and CAI-4 strains of C. albicans, and for
mRNAs that have a wide variety of decay rates and steady-state abundances. The
range of half-lives detected (from 4–168 min) shows that this method is effective
for mRNAs with widely varying half-lives. The mRNA decay rates obtained are compared with those for orthologous mRNAs from Saccharomyces cerevisiae. This procedure should work for a broad range of C. albicans strains and can be adapted to
other fungal species.
Keywords: comparative mRNA stability, ACT1, ADH1, EFG1, PGK1, 18S rRNA, mRNA
decay
Résumé
Une méthode pour déterminer les demi-vies d’ARNm dans le champignon polymorphe Candida albicans est décrite. Il utilise la croissance dans un milieu défini,
l’inhibition de la transcription avec la thiolutine (10–20 μg / mL) et le Northern
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blot quantitatif. La méthode est efficace pour les souches A72, SC5314 et CAI-4 de
C. albicans, et pour les ARNm qui ont une grande variété de taux de désintégration
et d’abondances à l’état d’équilibre. La gamme de demi-vies détectées (de 4 à 168
min) montre que cette méthode est efficace pour les ARNm avec des demi-vies très
variables. Les taux de désintégration des ARNm obtenus sont comparés à ceux des
ARNm orthologues de Saccharomyces cerevisiae. Cette procédure devrait fonctionner pour une large gamme de souches de C. albicans et peut être adaptée à d’autres
espèces fongiques.
Mots-clés: stabilité comparative de l’ARNm, ACT1, ADH1, EFG1, PGK1, ARNr 18S,
désintégration de l’ARNm
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Introduction
The polymorphic fungus Candida albicans is a commensal, found in
many different locations of the human body, that can become a major
fungal pathogen in immunocompromised individuals. Because of its
pathogenicity, C. albicans has become the 4th most common nosocomial infection in the United States. However, current antifungal treatments are only partly effective. Consequently, a significant number of
patients with nosocomial C. albicans infections who are treated with
current antifungals will die (Gudlaugsson et al. 2003; Macphail et al.
2002). Candida albicans is eukaryotic, sharing many biological processes with humans. Therefore, it is important to understand the regulation of gene expression of C. albicans to develop or improve treatment methods (Berman and Sudbery 2002).
The amount of protein that is synthesized by a cell depends on
the rate of synthesis of the protein, which in turn depends on the
steady-state level of the corresponding mRNA. The steady-state levels of mRNAs are determined by 2 factors: the rate of synthesis of
the specific mRNA, and the rate of decay of that mRNA. Thus, mRNA
stability is an important aspect of the regulation of gene expression.
Eukaryotic mRNA half-lives can vary from a few minutes in Saccharomyces cerevisiae to several hours in mammalian cells (Ross 1995).
Herrick et al. (1990) reported that for S. cerevisiae, most of the mRNA
half-lives are in the 3–45 min range.
However, half-lives of individual C. albicans mRNAs have not been
reported. Bulk half-lives for total poly(A)–containing RNA have been
determined using the pulse– chase technique, and were found to be
about 60 min (Bhattacharya and Datta 1975). This value is significantly
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longer than that reported for S. cerevisiae (Herrick et al. 1990). In this
paper, we describe the determination of mRNA half-lives of select C.
albicans mRNAs that represent both stable and unstable mRNAs. The
method works by shutting off the transcription of new mRNAs, using thiolutin, and then looking at the turnover of the already present
messages via quantitative Northern blotting. The method is effective
for all 3 of the C. albicans strains tested and for mRNAs that are present in both low and high abundance.

Materials and methods
Candida albicans strains and growth media
Three strains of Candida albicans were used: A72, SC5314, and CAI-4
(ura3::imm434/ura3::imm434) (Fonzi and Irwin 1993). A72 and
SC5314 are clinical isolates and SC5314 is the reference strain for the
Candida genome sequence (Arnaud et al. 2005). SC5314 and CAI-4
were obtained from Alexander Johnson, University of California at
San Francisco. A72 was obtained from Patrick Sullivan, University of
Otago, Dunedin, New Zealand, and A72 has been deposited with the
American Type Culture Collection (Rockville, MD) as strain MYA-2430.
All cultures were grown in either YPD or the defined glucose–phosphate–proline (GPP) (pH 4.8), which was supplemented with 50 μg/
mL uridine for CAI-4. YPD contains 1% yeast extract, 0.5% peptone,
and 2% glucose. GPP contains, per liter: 20 g glucose, 1.15 g l-proline, 0.55 g N-acetylglucosamine, 4 g KH2PO4, 3.2 g NaH2PO4, 0.5 g
MgSO4·7H2O, 1 mg CuSO4·5H2O, 1 mg ZnSO4·7H2O, 1 mg MnCl2, 1 mg
FeSO4, 20 μg biotin, 200 μg pyridoxine·HCl, and 200 mg thiamine·HCl
(pH 4.8). The glucose (20% w/v) and l-proline (100 mmol/L) were
autoclaved separately and added aseptically to the GPP to give a final
volume of 1 L.
Growth curves in the presence or absence of thiolutin
Thiolutin (Pfizer compound CP-4,092) was kindly provided by Edward Pagani, Manager Research and Development Operations, Central Research Division, Pfizer Inc. (Groton, Conn.). Thiolutin was solubilized to a final concentration of 10 mg/mL in dimethyl sulfoxide
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(DMSO). All growth conditions were at 30 °C with shaking at 200 r/
min, using a G10 gyrotory shaker (New Brunswick Scientific Inc., New
Brunswick, N.J.). An overnight culture of C. albicans was prepared in
5 mL YPD or GPP. From that overnight culture, 1 mL was added to 40
mL of prewarmed YPD or GPP in a 250 mL nephaloflask, and turbidity readings were taken with the Klett–Summerson colorimeter (Klett
Manufacturing Company Inc., New York), using a red filter, until the
culture reached 250 Klett units (roughly 0.5 OD600). Then, 10 mL of
culture was added to each of 3 prewarmed nephaloflasks. Thiolutin
in DMSO was added to 2 separate flasks, at a final concentration of 10
or 20 μg/mL, respectively. An equivalent amount of DMSO alone was
added to a third flask (DMSO-only control). The remaining 10 mL in
the original flask served as an untreated control. Klett readings were
taken every 5 to 10 min for the first hour, and as needed thereafter.
Viability counts were determined using a hemocytometer and methylene blue staining.
Uridine incorporation
H-uridine incorporation followed the protocol described by Bini et
al. (2002), with modifications. Candida albicans CAI-4 was grown in
GPP, supplemented with 0.175 μg/mL of nonradioactive uridine to an
OD600 of ca. 0.32. Portions (1.7 mL) of this culture were transferred to
sterile 25 mL Erlenmeyer flasks and equilibrated for 5 min at 30 °C
with shaking at 200 r/min. Radiolabeled uridine (5,6-3H, 37 Ci/mmol;
MP Biomedicals Inc., Irvin, Calif.) was added to make 0.013 μCi/mL.
Samples (10 μL) were collected in duplicate at 0, 10, 20, 40, and 60
min, and transferred to capped eppendorf tubes containing 490 μL of
unlabelled carrier cells (ca. 4 × 108 cells/mL), added to promote centrifugal recovery of trichloroacetic acid (TCA) precipitates. A total of
150 μL of cold 50% (w/v) TCA was added to each tube, to give a final
concentration of 11.5% (w/v) TCA. Samples were vortexed, allowed
to precipitate on ice for at least 5 min, and centrifuged at 15 000g,
whereupon the supernatants were discarded. Pellets were resuspended
in 25 μL of Tris–EDTA (pH. 8.0), placed in scintillation vials containing 2 mL of scintisafe F scintillation fluid (Fisher Scientific, Pittsburg,
Penn.), and counted on an LS1701 liquid scintillation counter (Beckman Instruments, Fullerton, Calif.).
3
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To assess thiolutin as a transcription inhibitor, after 60 min the culture was split into 3 flasks, each containing 500 μL of culture with,
respectively, thiolutin 10 μg/mL in DMSO (0.1%), DMSO (0.1%), and
no further additions. Samples (10 μL) were taken from each flask after 65, 70, 75, 80, 85, 90, 95, and 100 min and processed, as described
above.
mRNA half-lives
Candida albicans CAI-4 cells were grown overnight at 30 °C in YPD
or GPP, supplemented with 50 μg/mL uridine to an OD600 of 0.4–0.6.
Thiolutin (10 mg/mL in DMSO) was added to a final concentration of
10 μg/mL. Cells were then harvested at different time points after thiolutin was added, and total RNA was extracted using the hot phenol
method (Kebaara et al. 2003). Equal amounts of RNA (15 μg) were resolved on 1.0% agarose–formaldehyde gels, and the RNA was transferred to GeneScreen Plus (NEN Life Science Products Inc., Boston,
Mass.), using the capillary blot transfer protocol recommended by
the manufacturer. The Northern blots were probed sequentially with
ACT1, ADH1, EFG1, PGK1, and 18S DNA probes. The probes were pre
pared using PCR with SC5314 genomic DNA; the primers are listed in
Table 1. The probes were labeled with 32P using an oligolabelling kit
(RadPrime DNA labeling system; Invitrogen, Life Technologies, Carlsbad, Calif.). Northern blots were phosphorimaged using a Storm (Amersham Pharmacia Biotech Inc., Piscataway, N.J.). Half-lives were determined by plotting log10 of the percent mRNA remaining against
time, using SigmaPlot 2000, v. 6.10 (SPSS Science, Chicago, Ill.). Halflife measurements were done in triplicate.

Table 1. Primers used to generate probe fragments, and sizes of the probe fragments.
Gene
5′ primer
3′ primer
			
ACT1
ADH1
EFG1
PGK1
18S rRNA

AGTTATCGATAACGGTTCTG
CAAAAAGGATAATCCCGCAC
TTGACTACCAAGAATATAACC
CAATCAAGCGATTATCAATTG
TCAGTTATCGTTTATTTGAT

Probe fragment
size (bp)

AGATTTCCAGAATTTCACTC
CTGGAGCAGTGACTTTAGCGTG
CACTGGTAGCAGATATACTG
ATGTTACCATTTTCAGCAGA
TTCCTCTAAATGACCAAGTTTG

1124
1145
1128
1141
1621
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Results
Thiolutin inhibits C. albicans growth
A series of known transcription inhibitors were tested for their ability
to inhibit the growth of C. albicans. Thiolutin inhibited the growth of
C. albicans strains CAI-4 (Fig. 1), SC5314, and A72 when added at 10–
20 μg/mL. It also inhibits the growth of the yeast S. cerevisiae strain
Y166 (Jimenez et al. 1973) and strain DBY747 (Herrick et al. 1990)
when present at 2–4 μg/mL, by reversibly inhibiting RNA synthesis.
In contrast, actinomycin D, at concentrations up to 2 mg/mL, did not
inhibit the growth of C. albicans. This inactivity by actinomycin D is
in accord with the generalization that most fungi are impermeable to
actinomycin D.
Before conducting the C. albicans mRNA half-life experiments, it
was important to determine the concentration of thiolutin needed for
that particular strain and set of growth conditions. When grown in
YPD at 30 °C, 10 μg/mL thiolutin was required to inhibit C. albicans
CAI-4 (Fig. 1A); a higher concentration (20 μg/mL) was required for
C. albicans A72 (data not shown). For CAI-4 in YPD (Fig. 1A), after the
addition of 10 μg/mL thiolutin, there was a lag of about 25 min before
the cells stopped growing. In contrast, when C. albicans CAI-4 was
grown in the defined GPP with 50 μg/mL of uridine, the cells did not
exhibit a lag period between thiolutin addition and growth inhibition,
but they required 20 μg/mL of thiolutin to inhibit growth (Fig 1C and
D). Similar observations were made with C. albicans SC5314 (20 μg/
mL thiolutin) and C. albicans A72 (20 μg/mL of thiolutin); there was a
20–25 min lag period when grown in YPD but no lag period with GPP.
Viability of C. albicans cells in the presence of thiolutin was ≥90% but
in its absence was 100%. Viability of C. albicans cells was determined
using a hemocytometer with methylene blue staining.
Thiolutin treatment arrests transcription
To determine whether the growth arrest following thiolutin treatment
is accompanied by transcription inhibition, we measured the incorporation of 3H-uridine into TCA-precipitable RNA, as described elsewhere (Bini et al. 2002). C. albicans CAI-4 incorporates 3H-uridine
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Fig. 1. Effect of thiolutin on the growth of Candida albicans CAI-4. C. albicans CAI-4
grown in YPD (A and B) or glucosephosphate-proline (GPP) supplemented with uridine (C and D) in the presence or absence of thiolutin. The bottom panels (B and
D) are expansions of the boxes shown in the upper panels. ♦, control; □, dimethyl
sulfoxide (DMSO); Δ, thiolutin (10 μg/mL); ×, thiolutin (20 μg/mL); GPP, glucosephosphate-proline. Thiolutin curves are an average of 3 trials.

when grown in GPP supplemented with as little as 0.175 μg/mL of unlabelled uridine (Fig. 2), and the addition of thiolutin (10 μg/mL) inhibited 3H-uridine incorporation. A 10–15 min lag period was observed
before inhibition was complete (Fig. 2), after which the level of TCAprecipitable RNA remained fairly constant. As expected, cells grown in
the absence of thiolutin continued to incorporate 3H-uridine (Fig. 2).
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Fig. 2. Effect of thiolutin on RNA synthesis. Measurement of 3Huridine incorporation into C. albicans CAI-4 (a uridine auxotroph). Thiolutin (10 μg/mL in DMSO,
▼) or DMSO (○), both added at 60 min (indicated by arrow). Untreated control (●).

mRNA half-lives
mRNA half-lives of select transcripts were determined for C. albicans
CAI-4 grown in both YPD and GPP supplemented with uridine (Table
2; Fig. 3). The transcripts were selected to include mRNAs expected to
be stable (ACT1 mRNA, which encodes actin, and PGK1 mRNA, which
encodes phosphoglycerate kinase), unstable (EFG1 mRNA, which encodes enhanced filamentous growth factor, a transcription regulator),
and of intermediate stability (ADH1 mRNA, which encodes alcohol dehydrogenase). The half-life of 18S rRNA was also determined because
it is an RNA polymerase I transcript and it has been reported that thiolutin inhibits all 3 RNA polymerases in S. cerevisiae (Jimenez et al.
1973). The mRNA half-lives were measured for 60 min for ADH1 and
EFG1 mRNAs, and for 120 min for ACT1, ADH1, and PGK1 mRNAs. Figure 3 shows representative phosphorimages of PGK1 mRNA at different times after the inhibition of transcription. mRNA half-lives were
determined from the slopes of the lines plotting percent mRNA remaining against time after transcription arrest. The lag in growth inhibition observed when thiolutin was added to C. albicans CAI-4 in
YPD was also observed when determining mRNA half-lives (Fig. 3A),
although the lag was shorter (~10 min). There was also a short lag
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Table 2. Comparison of Candida albicans mRNA half-lives with previously determined
Saccharomyces cerevisiae mRNA half-lives.

Transcript
ACT1 mRNA
ADH1 mRNA
EFG1/SOK2 mRNA
PGK1 mRNA
18S rRNA

C. albicans mRNA
half-livesa (min)
30 °C

S. cerevisiae mRNA
half-lives (min)
30 °C
36 °C
rpb1–1b

34.6
33.3
4.3
43.3
168

135
—
—
>100
—

30
—
—
—
—

40
33
21
45
—

Reference
Li et al. 1999
Wang et al. 2002
Wang et al. 2002
Herrick et al. 1990
—

a. C. albicans half-lives were done in YPD at 30 °C.
b. rpb1–1 is a temperature sensitive allele of RNA polymerase II (Nonet et al. 1987).

Fig. 3. PGK1 mRNA half-life in YPD (A) and in GPP supplemented with uridine (B).
The phosphorimages show the PGK1 mRNA at different time points after the arrest
of transcription using thiolutin. The time points are indicated above the phosphorimages. The percent mRNA remaining was calculated by dividing the volume of a
particular band by the volume of the 0 min time point. The percent mRNA remaining vs. time was plotted using SigmaPlot.
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period observed for mRNA half-lives in GPP (Fig. 3B), even though
there was no lag period for growth inhibition under those conditions
(Fig. 1C and 1D). Transcript half-lives in YPD at 30 °C were determined
to be 34.6 ± 5 min for ACT1 mRNA, 43.3 ± 0.6 min for PGK1 mRNA,
33.3 ± 3 min for ADH1 mRNA, 4.3 ± 1.2 min for EFG1 mRNA, and 168
± 25 min for 18S rRNA.
The half-lives of ADH1 and PGK1 mRNAs were also determined for
CAI-4 grown in GPP supplemented with uridine. In this case, the ADH1
mRNA half-life in GPP was 33 ± 4.7 min, consistent with the 33.3 ± 3
min half-life determined in YPD. PGK1 mRNA half-life in GPP supplemented with uridine was 58 ± 12 min (Fig. 3B), whereas it was only
43.3 ± 0.6 min in YPD (Fig. 3A).

Discussion
We have devised an effective method for determining mRNA half-lives
in the dimorphic fungus C. albicans. No method for measuring Candida mRNA half-lives has been reported to date. Because mRNA halflife is an important gene regulatory mechanism, this method will be
an essential new tool for the study of gene regulation in C. albicans.
This method prevents new mRNA synthesis with the transcription inhibitor thiolutin. This procedure, adapted from one previously used
for S. cerevisiae (Herrick et al. 1990), had to be validated for C. albicans because of the distinctive features of C. albicans: unlike S. cerevisiae, it cannot uptake uracil; its genome contains ca. 2000 more genes
than does that of S. cerevisiae; strains of C. albicans can behave very
different physiologically; and C. albicans exhibits a temperature-regulated dimorphism, in that it usually grows as budding yeasts at 25–
30 °C and as mycelia at ≥37 °C (Odds 1988). For this last reason, the
most common method for determining mRNA half-lives in S. cerevisiae (based on a 24–36 °C shift in a strain containing a thermolabile
RNA polymerase II) would have limited utility in C. albicans, even if
the corresponding temperature-sensitive mutant was available. The
mRNA half-life method used here involves inhibiting transcription
with thiolutin and then measuring mRNA accumulation at subsequent
time points.
Thiolutin is a purine analog and the inability of C. albicans to take
up uracil, unlike S. cerevisiae, suggests that there is a fundamental
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difference in nucleoside uptake between C. albicans and S. cerevisiae. We found that thiolutin inhibited the growth of 3 C. albicans
strains: CAI-4 (Fig. 1), SC5314, and A72. Further, for C. albicans CAI4, we showed that growth inhibition was accompanied by transcription inhibition (Fig. 2). These strains were chosen because CAI-4 is
routinely used for molecular genetic and genomic studies (Magee et
al. 2003), SC5314 is the reference strain for the Candida genome sequence (Arnaud et al. 2005), and A72 is a well-characterized farnesolproducing and farnesol-responsive strain. Thus, the use of thiolutin
to inhibit transcription will be of broad utility to Candida researchers. Further, our method should be adaptable to other fungal species
sensitive to thiolutin.
Unstable mRNAs tend to be less abundant than stable mRNAs; thus,
mRNA half-lives are important in determining both the abundance of
a specific message and the way a particular gene is controlled. Thiolutin has been used successfully to measure mRNA half-lives in S. cerevisiae, and the decay measurements made with thiolutin were comparable to those done with other methods (Herrick et al. 1990). The
method described here can be used to determine mRNA half-lives in all
strains of C. albicans tested, with cells grown at many different temperatures in both minimal and rich media. However, in all cases, it is
important to tailor the thiolutin concentration to the strain of C. albicans and the growth conditions being studied. The choice of growth
conditions might also determine the length of the lag period observed
after thiolutin is added. For C. albicans CAI-4 grown in YPD, there was
a lag period of 25 min before growth inhibition (Fig. 1B), but the lag
period was only ~10 min before the inhibition of transcription (Fig.
3A). In contrast, for C. albicans CAI-4 grown in the defined GPP medium, there was no detectable lag before growth inhibition (Fig. 1C
and 1D) and a very short lag before transcription inhibition (Fig. 3B).
Similar mRNA half-life measurements in S. cerevisiae have shown a
lag period between thiolutin addition and transcription inhibition of
about 10 min (Herrick et al. 1990).
We have determined the half-lives of 5 transcripts that have varying stabilities. Based on their known stabilities in S. cerevisiae (Herrick et al. 1990), ACT1 and PGK1 mRNAs were expected to be stable;
they were found to be long lived in C. albicans as well (Table 2). Interestingly, the half-lives of PGK1 and ADH1 mRNAs were 43.3 and
33.3 min, respectively, in C. albicans, compared with 45 and 33 min,
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respectively, in S. cerevisiae (Herrick et al. 1990; Wang et al. 2002).
However, the PGK1 mRNA half-life of 43.3 min in YPD was increased
to 58 min when the cells were grown in GPP. This shows that mRNAs
of the same transcript can have different half-lives, depending on the
growth conditions. The ADH1 and ACT1 mRNA half-lives were also
similar to those for S. cerevisiae (Table 2). ADH1 mRNA showed intermediate stability, whereas EFG1 mRNA, which encodes a transcription
factor, was unstable, as was expected because of its regulatory function (Stoldt et al. 1997). This range of half-lives, from 4 to 168 min
(Table 2), shows that this method can be used to determine the stability of mRNAs with widely varying half-lives. It also allows the tentative conclusion that mRNA half-lives are generally equivalent for S.
cerevisiae and C. albicans. Finally, the method of inhibiting transcription with thiolutin can also be used with other RNA detection methods, such as RNase protection or quantitative reverse tran scription
(RT)-PCR. In both cases, thiolutin would be added to growing cells,
RNA would be extracted, and the amount of RNA remaining would be
determined at successive time points. Quantitative Northern blotting
is currently the method of choice, at least initially, because the size of
the RNA and the potential presence of multiple bands can be detected
on Northern blots. mRNA size is one indicator that the correct mRNA
is being detected. Multiple bands could arise from RNA isoforms or
cross hybridization to related or similar RNAs. It is more difficult to
discriminate between different RNA isoforms with RT-PCR or RNase
protection.
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